Can we develop neurally acting drugs for the treatment of migraine? - Wikidata - awgldk - TriplyDB

Can we develop neurally acting drugs for the treatment of migraine?

Can we develop neurally acting drugs for the treatment of migraine?

http://www.wikidata.org/entity/Q36240187

about

Non-Invasive Neuromodulation Using Time-Varying Caloric Vestibular Stimulation Pain perception and laser evoked potentials during menstrual cycle in migraine.Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans The vascular theory of migraine--a great story wrecked by the facts.Migraine: emerging treatment options for preventive and acute attack therapy.New migraine and pain research.Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey.Excitatory neurotransmitters in brain regions in interictal migraine patients.CGRP and migraine: could PACAP play a role too?The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study.Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.Health and disease, an orchestra of three players: Serotonin, orexins, and nitric oxide.Dipyridamole May Induce Migraine in Patients With Migraine Without Aura

P2860

Q30371913-678B7606-ECDE-46B7-88FE-B8F6AC11743F Q33504671-8FF00618-3A80-4ADD-8DBC-597A419B43A0 Q34906713-FA4D81A9-AAF4-44B7-B6C2-4CE7C96895A4 Q34908452-5FDE9D92-75C4-40DF-80CA-475B563BBD25 Q36580576-0F959B6E-E4D0-4D91-9F79-2EA32389A58A Q36787453-6A5E5E16-E642-4194-BFAD-666A3AB7901C Q36986892-825441B0-3449-49CD-AD4E-582FA57430CA Q37271327-4C1CD123-8A31-4ED3-A34D-4B3609C6CB0E Q37384128-17BD3452-E647-4779-8818-DFEFACDFF5B9 Q38105147-E303C585-2B62-4136-8F61-42719B9AFD6B Q39153634-FF80A97F-5724-44C9-BE5B-2279F3D8AFD7 Q40088209-A197DF14-E473-41A1-A4AA-CCC05D3193C3 Q46550880-2A1E5CCE-8946-408F-81F2-58741A1150C8 Q48221198-2EA25362-F644-4BC8-BE18-6F514215EF90 Q57024404-527392C4-7759-4868-B07E-759902F993E7

P2860

Can we develop neurally acting drugs for the treatment of migraine?

http://www.wikidata.org/entity/Q36240187

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Can we develop neurally acting drugs for the treatment of migraine?

@ast

Can we develop neurally acting drugs for the treatment of migraine?

@en

type

label

Can we develop neurally acting drugs for the treatment of migraine?

@ast

Can we develop neurally acting drugs for the treatment of migraine?

@en

prefLabel

Can we develop neurally acting drugs for the treatment of migraine?

@ast

Can we develop neurally acting drugs for the treatment of migraine?

@en

P1433

Q36240187-14C2C610-579B-48CA-AEA4-096C5C2A2AAB

P1476

Q36240187-2976957B-4D89-4FD7-B342-0F16C10508E1

P2093

Q36240187-D79FECCB-8447-4492-8793-7BFCDB0D3133

P2860

Q36240187-00134460-9197-4566-B243-B15E0D666296

Q36240187-0024431B-8FBD-4C12-8FDA-EA9418243BFE

Q36240187-013A6298-A7E8-4449-9FDA-6EF2A6D42533

Q36240187-0426BC76-8D68-498E-A8F6-A7FBC5EE7457

Q36240187-0658FA0D-71F3-450F-9453-AB94B39C6EFD

Q36240187-08E75882-1E36-4C09-BBD9-96B8707B2759

Q36240187-10B7D9DC-16A4-4881-A1EE-5A5A73286403

Q36240187-126F5AFD-FCA3-4943-9D3E-ADD9EF366044

Q36240187-163A59D6-B095-4841-984C-8970F6C0B8D6

Q36240187-165A3625-940E-47B4-8DCF-124887D92313

P2888

Q36240187-8CB2CBA4-F1A7-46C1-94FF-84DDF6D65DE6

P304

Q36240187-48228F11-589D-406C-840B-A871A48573B5

P31

Q36240187-9A45BDEA-D085-45E8-A83E-6B693653032D

P356

Q36240187-67965368-4B48-4D10-B4D1-53771F2FC12B

P433

Q36240187-0E459646-23E4-43B1-8ACB-FAA394DFCFD1

P478

Q36240187-DB347FE5-DF02-4D22-AB82-82928D6240DB

P577

Q36240187-8708AF3E-A24E-4328-9806-7DD5CE22E0D8

P5875

Q36240187-4C9272D4-C377-4CFB-8528-B8EC089063C3

P698

Q36240187-1030F364-904E-4B3F-97FA-9852049A4DB8

P921

Q36240187-F48DF59D-3454-4A79-A016-DC15FB897A88

P356

P1433

Nature Reviews Drug Discovery

P1476

Can we develop neurally acting drugs for the treatment of migraine?

@en

P2093

Peter J Goadsby

http://www.w3.org/2001/XMLSchema#string

P2860

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

Nocistatin, a peptide that blocks nociceptin action in pain transmission

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)

The global burden of disease study: implications for neurology

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

P2888

P304

741-750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD1822

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7639820

http://www.w3.org/2001/XMLSchema#string

P698

16121129

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder